A compliant 90471 encounter should include Dose administered Patient or guardian consent Provider signature or e-signature Injection site (left deltoid, right thigh, etc.) Route (IM, SQ, intradermal, or percutaneous) Observation period and any adverse reactions noted Vaccine name, manufacturer, lot number, and expiration date Vaccine Information Statement (VIS) provided to the patient (federal law requires VIS distribution for all CDC-covered vaccines) The ICD-10 code Z23 ( Encounter for immunization ) is the standard diagnosis pairing for routine preventive vaccines
His peptides come from compounding pharmacies that are making them despite the federal restrictions
Research-use discussions usually describe 100-300 mcg per SubQ injection on an empty stomach, often three times daily and spaced at least 4 hours apart
(Note: Its not clear what she meant by FDA pharmacies. The type of compounding pharmacy that the company uses is regulated by state boards of pharmacy, not the FDA.) As far as safety was concerned, the provider told me that people with cancer or who are breastfeeding shouldnt take peptides, and that I might have some soreness at the injection site
P.et al (1994)
The molecule is the main ingredient of three medications approved by the FDA (Food and Drug Administration, the US medical regulatory authority) for weight loss: Wegovy, Ozempic, and Rybelsus
